P.5.c.002 Sphingosine kinase 1 mediated signalling in Parkinson's disease animal model. Neuroprotective effect of fingolimod and a D2/D3 dopamine receptor agonist

Autor:	J. Strosznajder, P. Kosson, Ł. Przykaza, P. Boguszewski, J. Moty
Rok vydání:	2015
Předmět:	Pharmacology Agonist Parkinson's disease biology medicine.drug_class business.industry medicine.disease Fingolimod Neuroprotection Psychiatry and Mental health Signalling Animal model Neurology Sphingosine kinase 1 Dopamine receptor medicine biology.protein Pharmacology (medical) Neurology (clinical) business Biological Psychiatry medicine.drug
Zdroj:	European Neuropsychopharmacology. 25:S586-S587
ISSN:	0924-977X
DOI:	10.1016/s0924-977x(15)30824-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::506b33c9154160ff6630429bed04d054 https://doi.org/10.1016/s0924-977x(15)30824-5 Zobrazit plný text záznamu Full Text from ScienceDirect